Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications

MS Castaneto, DA Gorelick, NA Desrosiers… - Drug and alcohol …, 2014 - Elsevier
Background Synthetic cannabinoids (SC) are a heterogeneous group of compounds
developed to probe the endogenous cannabinoid system or as potential therapeutics …

Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications

MS Castaneto, DA Gorelick, NA Desrosiers… - Drug and alcohol …, 2014 - safetylit.org
BACKGROUND: Synthetic cannabinoids (SC) are a heterogeneous group of compounds
developed to probe the endogenous cannabinoid system or as potential therapeutics …

Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications.

MS Castaneto, DA Gorelick, NA Desrosiers… - Drug and Alcohol …, 2014 - psycnet.apa.org
Background: Synthetic cannabinoids (SC) are a heterogeneous group of compounds
developed to probe the endogenous cannabinoid system or as potential therapeutics …

Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications

MS Castaneto, DA Gorelick, NA Desrosiers… - Drug and Alcohol …, 2014 - infona.pl
Synthetic cannabinoids (SC) are a heterogeneous group of compounds developed to probe
the endogenous cannabinoid system or as potential therapeutics. Clandestine laboratories …

[引用][C] Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications

MS Castaneto, DA Gorelick, NA Desrosiers… - Drug and Alcohol …, 2014 - cir.nii.ac.jp

Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications

MS Castaneto, DA Gorelick… - Drug and alcohol …, 2014 - pubmed.ncbi.nlm.nih.gov
Background Synthetic cannabinoids (SC) are a heterogeneous group of compounds
developed to probe the endogenous cannabinoid system or as potential therapeutics …

[PDF][PDF] Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications

MS Castanetoa, DA Gorelickc, NA Desrosiersa… - academia.edu
abstract Background: Synthetic cannabinoids (SC) are a heterogeneous group of
compounds developed to probe the endogenous cannabinoid system or as potential …

Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.

MS Castaneto, DA Gorelick, NA Desrosiers… - Drug and Alcohol …, 2014 - europepmc.org
Background Synthetic cannabinoids (SC) are a heterogeneous group of compounds
developed to probe the endogenous cannabinoid system or as potential therapeutics …

[HTML][HTML] Synthetic Cannabinoids: Epidemiology, Pharmacodynamics, and Clinical Implications

MS Castaneto, DA Gorelick, NA Desrosiers… - Drug and alcohol …, 2014 - ncbi.nlm.nih.gov
Background Synthetic cannabinoids (SC) are a heterogeneous group of compounds
developed to probe the endogenous cannabinoid system or as potential therapeutics …

[PDF][PDF] Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications

MS Castanetoa, DA Gorelickc, NA Desrosiersa… - academia.edu
abstract Background: Synthetic cannabinoids (SC) are a heterogeneous group of
compounds developed to probe the endogenous cannabinoid system or as potential …